1951 — Jinxin Fertility Balance Sheet
0.000.00%
- HK$6.84bn
- HK$9.31bn
- CNY2.81bn
Annual balance sheet for Jinxin Fertility, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 745 | 1,928 | 1,401 | 853 | 571 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 157 | 517 | 370 | 346 | 403 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,652 | 2,543 | 1,904 | 1,342 | 1,090 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,279 | 1,493 | 3,095 | 3,123 | 3,271 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 9,163 | 12,825 | 15,232 | 14,896 | 14,982 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 555 | 1,072 | 2,764 | 1,690 | 2,119 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Liabilities | 1,880 | 4,280 | 6,592 | 4,805 | 4,707 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 7,283 | 8,545 | 8,640 | 10,091 | 10,274 |
| Total Liabilities & Shareholders' Equity | 9,163 | 12,825 | 15,232 | 14,896 | 14,982 |
| Total Common Shares Outstanding |